Filing Details
- Accession Number:
- 0001104659-10-009828
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-25 12:00:00
- Reporting Period:
- 2010-02-23
- Filing Date:
- 2010-02-25
- Accepted Time:
- 2010-02-25 19:19:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1028318 | Micrus Endovascular Corp | MEND | Surgical & Medical Instruments & Apparatus (3841) | 232853441 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1232258 | Ltd Cayman Bioventures Hbm | Centennial Towers, 3Rd Flr. 2454 West Bay Road Grand Cayman E9 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-02-23 | 40,000 | $20.02 | 1,711,599 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-02-24 | 30,000 | $19.94 | 1,681,599 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.72 to 20.14, inclusive. The undersigned undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.39 to 20.36, inclusive. The undersigned undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
Billionaire Hedge Funds
